TCL Archive Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System March 5, 1999
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE January 24, 1997
TCL Archive Panel To Look At Cancer Centers Program, Starting With West Coast, Hawaii Meetings This Year, Next January 27, 1984
